Nano-drug delivery systems integrated with low radiation doses for enhanced therapeutic efficacy in cancer treatment

Figure 5 Glioblastoma nanomedicine research. A: A comparison illustration of the countries with the highest citations in glioblastoma nanomedicine research. Each bar illustrates a country's total citation count, offering insight into regional research influence and the acknowledgment of scholarly work performed by scholars in different nations. These graphic highlights the substantial contributions of the United States, China, and European countries to the subject; B: Graphical depiction of significant institutions' contributions to glioblastoma nanomedicine research, ordered by publication volume. Each bar signifies an institution, such as Johns Hopkins University, illustrating the premier research organizations that propel innovation and discovery within this specialized domain; C: Journals classified by their publication volume in glioblastoma nanomedicine, in accordance with Bradford’s Law. Journals are ranked based on the volume of published papers, with the 'International Journal of Nanomedicine' at the forefront. The distribution highlights journals that function as important venues for the dissemination of research in nanomedicine applications for oncology.